SCHEMBL30245247

SCHEMBL30245247

COc1cccc(CN(Cc2ccc(N3CCCC3)cc2)c2ccnc(COCCOCCN3CCOCC3)c2)c1

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ TSHR P16473 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ LTA4H P09960 1/20 0.41
▸ F2R P25116 2/20 0.40
▸ ABCB1 P08183 5/20 0.40
▸ SIGMAR1 Q99720 2/20 0.40
▸ HRH3 Q9Y5N1 2/20 0.39
▸ DRD2 P14416 1/20 0.39
▸ DRD4 P21917 1/20 0.39
▸ ROCK2 O75116 2/20 0.38
▸ ROCK1 Q13464 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25250223 1.00 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2NPSR1LTA4H
SCHEMBL25261349 0.98 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2NPSR1LTA4H
SCHEMBL30245335 0.98 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2NPSR1LTA4H
SCHEMBL30244972 0.97 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2NPSR1LTA4H
SCHEMBL29194515 0.97 ALDH1A1 (0.43) ALDH1A1TSHRSMN1; SMN2NPSR1LTA4H
SCHEMBL25292335 0.95 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2NPSR1ABCB1
SCHEMBL25290109 0.95 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2NPSR1LTA4H
SCHEMBL30245104 0.95 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2NPSR1LTA4H
SCHEMBL30245464 0.95 ALDH1A1 (0.42) ALDH1A1TSHRSMN1; SMN2NPSR1ABCB1
SCHEMBL29194579 0.95 ALDH1A1 (0.44) ALDH1A1TSHRSMN1; SMN2NPSR1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4384516-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS Texas Heart Institute (US) 2024-06-19 — — EP claimed
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO claimed
WO-2023018472-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-02-16 — — WO claimed
EP-4384516-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS Texas Heart Institute (US) 2024-06-19 — — EP disclosed
WO-2023018472-A9 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-07-13 — — WO disclosed
WO-2023018472-A1 AMINOARYL-INTEGRIN AGONISTS COMPOUNDS TEXAS HEART INSTITUTE (US) 2023-02-16 — — WO disclosed
Send feedback